Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adecoagro SA (AGRO) vs Eli Lilly And Co (LLY) Price & Performance

Adecoagro SATrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Adecoagro SA vs Eli Lilly And Co — how do they compare? Adecoagro SA trades at $9.67 (market cap $1.39B), while Eli Lilly And Co trades at $1,215.01 (market cap $1.10T). The key difference: Eli Lilly And Co is far larger — about 791.4× Adecoagro SA's market cap, and Adecoagro SA pays the higher dividend (3.07%). Which is the better fit depends on your goals.

AGROLLY
Market Cap
$1.39B$1.10T
Sector
TechnologyHealth
52-Week High
$15.25$1.24K
52-Week Low
$7.13$639.43
Enterprise Value
$3.43B$1.14T
Dividend Yield
3.07%0.56%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Adecoagro SA

AGRO trades at $9.45, up 0.96% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported negative net income of -$8.35M for 2025 despite $1.43B revenue, though 2026 projections show potential profitability improvement. Recent acquisition of Caarapó Mill expands operational footprint while analyst consensus leans neutral with 50% hold ratings.

Outlook remains cautious with elevated P/E ratio of 536.67 offset by attractive P/B of 0.79. Key risks include commodity volatility and integration challenges from recent acquisitions. The stock presents value opportunity if 2026 profitability targets are achieved, but requires careful monitoring of earnings trajectory.

Eli Lilly And Co

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Adecoagro SA

Adecoagro is a South American agricultural company. It operates a diversified business including farming crops, rice, and dairy, as well as producing sugar, ethanol, and renewable energy from its industrial facilities.

Read more on AGRO

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY